167 related articles for article (PubMed ID: 18029173)
1. Synthesis and evaluation of novel heterocyclic MMP inhibitors.
Hayashi R; Jin X; Cook GR
Bioorg Med Chem Lett; 2007 Dec; 17(24):6864-70. PubMed ID: 18029173
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 8-amino-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives as glycogen synthase kinase-3 (GSK-3) inhibitors.
Chun K; Park JS; Lee HC; Kim YH; Ye IH; Kim KJ; Ku IW; Noh MY; Cho GW; Kim H; Kim SH; Kim J
Bioorg Med Chem Lett; 2013 Jul; 23(13):3983-7. PubMed ID: 23683591
[TBL] [Abstract][Full Text] [Related]
3. The design and synthesis of novel SGLT2 inhibitors: C-glycosides with benzyltriazolopyridinone and phenylhydantoin as the aglycone moieties.
Guo C; Hu M; DeOrazio RJ; Usyatinsky A; Fitzpatrick K; Zhang Z; Maeng JH; Kitchen DB; Tom S; Luche M; Khmelnitsky Y; Mhyre AJ; Guzzo PR; Liu S
Bioorg Med Chem; 2014 Jul; 22(13):3414-22. PubMed ID: 24842618
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient synthesis of HIV NNRTI doravirine.
Gauthier DR; Sherry BD; Cao Y; Journet M; Humphrey G; Itoh T; Mangion I; Tschaen DM
Org Lett; 2015 Mar; 17(6):1353-6. PubMed ID: 25751537
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
Özdemir A; Sever B; Altıntop MD; Temel HE; Atlı Ö; Baysal M; Demirci F
Molecules; 2017 Jul; 22(7):. PubMed ID: 28677624
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and structure-activity relationship of novel and effective apixaban derivatives as FXa inhibitors containing 1,2,4-triazole/pyrrole derivatives as P2 binding element.
Wang Y; Sun X; Yang D; Guo Z; Fan X; Nie M; Zhang F; Liu Y; Li Y; Wang Y; Gong P; Liu Y
Bioorg Med Chem; 2016 Nov; 24(21):5646-5661. PubMed ID: 27663548
[TBL] [Abstract][Full Text] [Related]
8. 1-Hydroxy-2-pyridinone-based MMP inhibitors: synthesis and biological evaluation for the treatment of ischemic stroke.
Zhang YM; Fan X; Chakaravarty D; Xiang B; Scannevin RH; Huang Z; Ma J; Burke SL; Karnachi P; Rhodes KJ; Jackson PF
Bioorg Med Chem Lett; 2008 Jan; 18(1):409-13. PubMed ID: 17981034
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of triazole functionalized ring-fused 2-pyridones as antibacterial agents.
Bengtsson C; Lindgren AE; Uvell H; Almqvist F
Eur J Med Chem; 2012 Aug; 54():637-46. PubMed ID: 22749393
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors.
Nara H; Sato K; Kaieda A; Oki H; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M
Bioorg Med Chem; 2016 Dec; 24(23):6149-6165. PubMed ID: 27825552
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.
Zhao Z; Harrison ST; Schubert JW; Sanders JM; Polsky-Fisher S; Zhang NR; McLoughlin D; Gibson CR; Robinson RG; Sachs NA; Kandebo M; Yao L; Smith SM; Hutson PH; Wolkenberg SE; Barrow JC
Bioorg Med Chem Lett; 2016 Jun; 26(12):2952-2956. PubMed ID: 27133481
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach.
Nara H; Kaieda A; Sato K; Naito T; Mototani H; Oki H; Yamamoto Y; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M
J Med Chem; 2017 Jan; 60(2):608-626. PubMed ID: 27966948
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP).
Haffner CD; Diaz CJ; Miller AB; Reid RA; Madauss KP; Hassell A; Hanlon MH; Porter DJ; Becherer JD; Carter LH
Bioorg Med Chem Lett; 2008 Aug; 18(15):4360-3. PubMed ID: 18606544
[TBL] [Abstract][Full Text] [Related]
14. Progress towards water-soluble triazole-based selective MMP-2 inhibitors.
Fabre B; Filipiak K; Zapico JM; Díaz N; Carbajo RJ; Schott AK; Martínez-Alcázar MP; Suárez D; Pineda-Lucena A; Ramos A; de Pascual-Teresa B
Org Biomol Chem; 2013 Oct; 11(38):6623-41. PubMed ID: 23989288
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs.
Wang Z; Yu Z; Kang D; Zhang J; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Bioorg Med Chem; 2019 Feb; 27(3):447-456. PubMed ID: 30606670
[TBL] [Abstract][Full Text] [Related]
16. Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation.
Albelwi FF; Teleb M; Abu-Serie MM; Moaty MNAA; Alsubaie MS; Zakaria MA; El Kilany Y; Aouad MR; Hagar M; Rezki N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638665
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs.
Cao Y; Zhang Y; Wu S; Yang Q; Sun X; Zhao J; Pei F; Guo Y; Tian C; Zhang Z; Wang H; Ma L; Liu J; Wang X
Bioorg Med Chem; 2015 Jan; 23(1):149-59. PubMed ID: 25468035
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase.
Li R; Xue L; Zhu T; Jiang Q; Cui X; Yan Z; McGee D; Wang J; Gantla VR; Pickens JC; McGrath D; Chucholowski A; Morris SW; Webb TR
J Med Chem; 2006 Feb; 49(3):1006-15. PubMed ID: 16451066
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approach.
Major Jourden JL; Cohen SM
Angew Chem Int Ed Engl; 2010 Sep; 49(38):6795-7. PubMed ID: 20715043
[No Abstract] [Full Text] [Related]
20. Identification of Broad-Spectrum MMP Inhibitors by Virtual Screening.
Gimeno A; Cuffaro D; Nuti E; Ojeda-Montes MJ; Beltrán-Debón R; Mulero M; Rossello A; Pujadas G; Garcia-Vallvé S
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
